EBOS Group Limited (FRA:EJG)

Market Cap	2.23B -40.0%
Revenue (ttm)	7.41B +3.5%
Net Income	130.36M -6.7%
EPS	0.64 -11.1%
Shares Out	n/a
PE Ratio	17.10
Forward PE	13.96
Dividend	0.63 (5.86%)
Ex-Dividend Date	Mar 5, 2026

Volume	n/a
Average Volume	151
Open	10.30
Previous Close	10.20
Day's Range	10.30 - 10.30
52-Week Range	10.20 - 20.80
Beta	n/a
RSI	33.23
Earnings Date	May 25, 2026

About EBOS Group

EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and ...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1922
• Employees: 5,800
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: EJG

Financial Performance

In fiscal year 2025, EBOS Group's revenue was 12.27 billion, a decrease of -6.99% compared to the previous year's 13.19 billion. Earnings were 215.14 million, a decrease of -20.77%.

Financial numbers in AUD